Abstracts tagged "Biologics and tocilizumab"

Abstract Number: 581 • 2015 ACR/ARHP Annual Meeting
Optimization of Treatment Intervals of Tocilizumab and Golimumab By Measuring Serum Trough Levels in Rheumatoid Arthritis Patients
Yoshinobu Matsuura¹, Masashi Narazaki², Masayuki Nishide², Yasuhiro Kato², Hideki Yorifuji², Toru Hirano³, Yoshihito Shima³, Toshio Tanaka², Atsushi Ogata⁴ and Atsushi Kumanogoh³, ¹Internal Medicine, Allergy and Rheumatic diseases, Osaka University Graduate School of Medicine, Suita, Japan, ²Osaka University Graduate School of Medicine, Suita, Japan, ³Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, ⁴Osaka University Graduate School of Medicine and NTT West Osaka Hospital, Osaka, Japan
Background/Purpose: Biologic agents have dramatically improved the outcome of rheumatoid arthritis (RA) patients. However, the administration dose and treatment intervals of these agents are usually…